An Assessment of the Safety of Pediatric Ibuprofen: Title and subTitle BreakA Practitioner-Based Randomized Clinical Trial FREE

Samuel M. Lesko, MD, MPH; Allen A. Mitchell, MD

[+] Author Affiliations

Drs Lesko and Mitchell served as consultants to McNeil Consumer Products Co, Fort Washington, Pa, during the design phase of the trial.

Reprint requests to the Slone Epidemiology Unit, 1371 Beacon St, Brookline, MA 02146 (Dr Lesko).

JAMA. 1995;273(12):929-933. doi:10.1001/jama.1995.03520360043037

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

Objective. —To test the hypothesis that ibuprofen increases the risk of hospitalization for gastrointestinal bleeding, renal failure, or anaphylaxis among febrile children.

Design. —Randomized double-blind acetaminophen-controlled trial.

Setting. —Outpatient pediatric and family medicine practices.

Patients. —A total of 84192 children.

Intervention. —Patients were randomly assigned to receive 12 mg/kg of acetaminophen, 5 mg/kg of ibuprofen, or 10 mg/kg of ibuprofen.

Main Outcome Measures. —Hospitalizations for acute gastrointestinal bleeding, acute renal failure, and anaphylaxis.

Results. —A total of 277 patients (0.3%) were unavailable for follow-up. Overall, 795 participants (1%) were hospitalized, primarily for infectious diseases; hospitalization rates did not differ according to treatment group. Four children had diagnoses of acute, nonmajor gastrointestinal bleeding (two in each ibuprofen dosage group); among ibuprofen-treated children, the observed risk of gastrointestinal bleeding, 7.2 per 100000 (95% confidence interval, 2 to 18 per 100000), was not significantly different from the risk among acetaminophen-treated children (P=.31). There were no hospitalizations for acute renal failure or anaphylaxis; the upper 95% confidence bound for the risk of either of these outcomes was 5.4 per 100 000 ibuprofen-treated children. Among a number of other possibly serious adverse drug events, low white blood cell count was marginally associated with ibuprofen treatment. Because this association was observed in the setting of multiple comparisons and white blood cell counts may have been low before treatment, causation is unclear.

Conclusions. —The risk of hospitalization for gastrointestinal bleeding, renal failure, or anaphylaxis was not increased following short-term use of ibuprofen in children. These data, however, provide no information on the risks of less severe outcomes or the risks of prolonged ibuprofen use.(JAMA. 1995;273:929-933)

REFERENCES

ABSTRACT | REFERENCES

Sheth UK, Gupta K, Paul T, Pispati PK. Measurement of antipyretic activity of ibuprofen and paracetamol in children. J Clin Pharmacol . 1980;; 20:672-675.

Wilson G, Guerra AJ, Santos NT. Comparative study of the antipyretic effect of ibuprofen (oral suspension) and paracetamol (suppositories) in paediatrics. J Int Med Res . 1984;;12:250-254.

Kandoth PW, Joshi MK, Joshi VR, Satoskar RS. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. J Int Med Res . 1984;;12:292-297.

Phadke MA, Paranjape PV, Joshi AS. Ibuprofen in children with infective disorders: antipyretic efficacy. Br J Clin Pract . 1985;;39:437-440.

Kotob A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. J Int Med Res . 1985;;13:122-126.

Amdekar YK, Desai RZ. Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. Br J Clin Pract . 1985;;39:140-143.

Heremans G, Dehaen F, Rom N, et al. A single-blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. Br J Clin Pract . 1988;;42:245-247.

Walson PD, Galletta G, Braden NJ, Alexander L. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther . 1989;; 46:9-17.

Marriott SC, Stephenson TJ, Hull D, et al. A dose ranging study of ibuprofen suspension as an antipyretic. Arch Dis Child . 1991;;66:1037-1041.

Wilson JT, Brown RD, Kearns GL, et al. Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr . 1991;;119:803-811.

Bertin L, Pons G, d'Athis P, et al. Randomized, double-blind, multicenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children. J Pediatr . 1991;;119:811-814.

Kauffman RE, Sawyer LA, Scheinbaum ML. Antipyretic efficacy of ibuprofen vs acetaminophen. AJDC . 1992;;146:622-625.

Walson PD, Galletta G, Chomilo F, et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. AJDC . 1992;;146:626-632.

Nahata MC, Powell DA, Durrell DE, Miller MA, Gupta N. Efficacy of ibuprofen in pediatric patients with fever. Int J Clin Pharmacol Ther Toxicol . 1992;;30:94-96.

Schachtel BP, Thoden WR. A placebo-controlled model for assaying systemic analgesics in children. Clin Pharmacol Ther . 1993;;53:593-601.

Miettinen O. Efficacy of therapeutic practice: will epidemiology provide the answers? In: Melmon KL, ed. Drug Therapeutics: Concepts for Physicians . New York, NY: Elsevier North Holland; 1980;:201-208.

Hurwitz ES, Nelson DB, Davis C, et al. National surveillance for Reye syndrome: a five-year review. Pediatrics . 1982;;70:895-900.

Friedman LM, Furberg CD, DeMets DL. Monitoring response variables. In: Fundamentals of Clinical Trials . 2nd ed. Littleton, Mass: PSG Publishing Co; 1985;:138-155.

Mehta C, Patel N. StatXact: Statistical Software for Exact Nonparametric Inference, Version 2 . Cambridge, Mass: Cytel Software Corp; 1989;.

Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: differences and similarities. N Engl J Med . 1991;;324:1716-1725.

Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther . 1993;;53:485-494.

Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med . 1984;;310:563-572.

Mann JFE, Goerig M, Brune K, Luft FC. Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol . 1993;;39:1-6.

Giannini EH, Brewer EJ, Miller ML, et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis: Pediatric Rheumatology Collaborative Study Group. J Pediatr . 1990;;117:645-652.

Steans A, Manners PJ, Robinson IG. A multicentre, long-term evaluation of the safety and efficacy of ibuprofen syrup in children with juvenile chronic arthritis. Br J Clin Pract . 1990;;44:172-175.

van Biljon G. Reversible renal failure associated with ibuprofen in a child: a case report. S Afr Med J . 1989;;76:34-35.

Mclntire SC, Rubenstein RC, Gartner JC, Gilboa N, Ellis D. Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use. Pediatrics . 1993;;93:459-460.

Wattad A, Feehan T, Shepard FM. A unique complication of nonsteroidal anti-inflammatory drug use. Pediatrics . 1994;;93:693.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal